Olanzapine Injection, Powder, For Solution
Product Images NDC 31722-308
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 31722-308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Olanzapinecartonlabel (Olanzapinecartonlabel)
This appears to be a medication label for a drug called Olanzapine. It comes in a single-dose vial for intramuscular use only, containing 10mg of olanzapine. The medication must be stored at controlled room temperature and used within an hour after reconstitution. The medication is manufactured and distributed by Camber Pharmaceuticals and Aspiro Pharma Limited. The label also includes NDC numbers and contact information for USP.*
Olanzapineforinj10mgvialstructure (Olanzapineforinj10mgvialstructure)
Olanzapineforinjaspirologo (Olanzapineforinjaspirologo)
Olanzapineviallabel (Olanzapineviallabel)
This is a description for Olanzapine, a sterile injection that comes in a single dose vial for intramuscular use only. The label indicates it is manufactured by Aspiro Pharma Limited in India, under Mfg. Lic. No.: 36/MD/AP/2013[FIG := 2XXXXXX, and packaged for Camber Pharmaceuticals, Inc. of Piscataway, NJ. It provides the NDC number 31722-308-01 and a contact number for use in the US. The accompanying literature contains dosage, reconstitution instructions, N lot, and method of administration. The product has an expiration date indicated with "Exp: 15x12mm".*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.